| Gene ID | 857 |
| Symbol | CAV1 |
| Synonymous | BSCL3|CGL3|LCCNS|MSTP085|PPH3|VIP21 |
| Full name | caveolin 1, caveolae protein, 22kDa |
| Gene description | caveolin-1|cell growth-inhibiting protein 32 |
| Cytoband | 7q31.1 |
| Gene type | protein-coding |
| Synonymous | MIM:601047; HGNC:HGNC:1527; Ensembl:ENSG00000105974; HPRD:03028; Vega:OTTHUMG00000023413 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Endocytosis;KEGG PATHWAY;hsa04144 |
Pathway | Direct p53 effectors;PID Curated;200101 |
Pathway | ALK1 signaling events;PID Curated;200126 |
Pathway | Basigin interactions;PID Reactome;500308 |
Pathway | VEGFR1 specific signals;PID Curated;200151 |
Pathway | ion channels and their functional role in vascular endothelium;PID BioCarta;100055 |
Pathway | NOSTRIN mediated eNOS trafficking;PID Reactome;500851 |
Pathway | PDGFR-alpha signaling pathway;PID Curated;200140 |
Pathway | Bacterial invasion of epithelial cells;KEGG PATHWAY;hsa05100 |
Pathway | TNF receptor signaling pathway;PID Curated;200086 |
Pathway | Focal adhesion;KEGG PATHWAY;hsa04510 |
Pathway | TGF-beta receptor signaling;PID Curated;200195 |
Pathway | corticosteroids and cardioprotection;PID BioCarta;100156 |
Pathway | eNOS activation;PID Reactome;500849 |
Pathway | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis;PID Reactome;500799 |
Pathway | Metabolism of nitric oxide;Reactome;REACT:12508 |
Pathway | Signaling events mediated by VEGFR1 and VEGFR2;PID Curated;200161 |
Pathway | Insulin Pathway;PID Curated;200012 |
Pathway | Canonical Wnt signaling pathway;PID Curated;200064 |
Pathway | Integrin signalling pathway;PANTHER;P00034 |
Pathway | actions of nitric oxide in the heart;PID BioCarta;100094 |
Pathway | Signaling events mediated by PTP1B;PID Curated;200033 |
Pathway | Viral myocarditis;KEGG PATHWAY;hsa05416 |
Pathway | Hemostasis;Reactome;REACT:604 |
Pathway | integrin signaling pathway;PID BioCarta;100123 |
Pathway | vegf hypoxia and angiogenesis;PID BioCarta;100006 |
Disease | Scleroderma;FunDO |
Disease | Primary biliary cirrhosis;FunDO |
Disease | Hypertension;FunDO |
Disease | Electrocardiographic traits;NHGRI |
Disease | Genetic disorders;KEGG DISEASE |
Disease | Lipodystrophy, congenital generalized, type 3;OMIM |
Disease | Systemic scleroderma;FunDO |
Disease | CARDIOVASCULAR;GAD |
Disease | Bladder cancer;FunDO |
Disease | Congenital generalized lipodystrophy;KEGG DISEASE;H00419 |
Disease | Pulmonary fibrosis;FunDO |
Disease | prostate cancer;GAD |
Disease | Other genetic disorders;KEGG DISEASE |
Disease | Glaucoma (primary open-angle);NHGRI |
Disease | Cancer;FunDO |
Disease | PR interval;NHGRI |
Disease | Oral cancer;FunDO |
Disease | CANCER;GAD |
Disease | Rabies;FunDO |
Disease | blood pressure, arterial hypertension;GAD |
Sequence Information | |
|---|---|
Nucleotide Sequence | >857 : length: 3212 TAAAGCACAGCCCAGGGAAACCTCCTCACAGTTTTCATCCAGCCACGGGCCAGCATGTCTGGGGGCAAATACGTAGACTCGGAGGTAGGCATCCGTGGGGGGGCGCCGGCTCGGGCGTGC GGGGAGTGTCCGCTTCTGCTATCTGCCTCTCCAAATATCCCGACTGCTGCCCTGGCCCCAGCCCTCTCTCCACTTCGGAGCACTCCTCTGGCGTTGGCACCGCTGAGGAATGGGCCTGGG CGGGGAGGTGAAGAGAAGCCAGGAATGTTTTATGTTTTCCTAATGGAGAGGGGGCCTAGGGAGCCCCTGAGCTAGGAGGACACGGAAAAGGGGATTGGGGTCCTGAGATTGGGTCTGTTG GGCCCAGGACGCGTTTTCTGGATGGGTCTAGGATGCTCCCTTGTCGCGGGACCCCCGCGGTCCGGCCCTGCCTGCTGGGGGTTCGAAGAGGTGGAGTGCAGGGTGGAGGTGTTATTTACC CGAGTCCTGGGGACAGTCCCCGGGACTCTCCGCCAGGCGCCCAGACCGGCAGGTCCCGCAGGCGGCGCGCGGTGTGTTTGCACTTTCCAAAGTTCTTGAACCATCTCAAGAACTCCTTCT GCATCTTGGCGTCTGGCAGGGGTGTTCCGAGAGAGGTAGACCTCCCCTCCCCAAACTGCCACCATCACTTCCAACGCCCTCCACGCGCTGGAGCTCTGCCCGGGTGTGGAAACCTCGTCT TCCAACACGTAGCTGCCCTTCAGCCACCCGCCCGCAGCCTGGGAGTGCCCTGAGGGTGGGTCGGGGGAGCTGCGCAGGGACATCTCTACACCGTTCCCATCCGGGAACAGGGCAACATCT ACAAGCCCAACAACAAGGCCATGGCAGACGAGCTGAGCGAGAAGCAAGTGTACGACGCGCACACCAAGGAGATCGACCTGGTCAACCGCGACCCTAAACACCTCAACGATGACGTGGTCA AGATTGACTTTGAAGATGTGATTGCAGAACCAGAAGGGACACACAGTTTTGACGGCATTTGGAAGGCCAGCTTCACCACCTTCACTGTGACGAAATACTGGTTTTACCGCTTGCTGTCTG CCCTCTTTGGCATCCCGATGGCACTCATCTGGGGCATTTACTTCGCCATTCTCTCTTTCCTGCACATCTGGGCAGTTGTACCATGCATTAAGAGCTTCCTGATTGAGATTCAGTGCATCA GCCGTGTCTATTCCATCTACGTCCACACCGTCTGTGACCCACTCTTTGAAGCTGTTGGGAAAATATTCAGCAATGTCCGCATCAACTTGCAGAAAGAAATATAAATGACATTTCAAGGAT AGAAGTATACCTGATTTTTTTTCCTTTTAATTTTCCTGGTGCCAATTTCAAGTTCCAAGTTGCTAATACAGCAACAATTTATGAATTGAATTATCTTGGTTGAAAATAAAAAGATCACTT TCTCAGTTTTCATAAGTATTATGTCTCTTCTGAGCTATTTCATCTATTTTTGGCAGTCTGAATTTTTAAAACCCATTTAAATTTTTTTCCTTACCTTTTTATTTGCATGTGGATCAACCA TCGCTTTATTGGCTGAGATATGAACATATTGTTGAAAGGTAATTTGAGAGAAATATGAAGAACTGAGGAGGAAAAAAAAAAAAAAGAAAAGAACCAACAACCTCAACTGCCTACTCCAAA ATGTTGGTCATTTTATGTTAAGGGAAGAATTCCAGGGTATGGCCATGGAGTGTACAAGTATGTGGGCAGATTTTCAGCAAACTCTTTTCCCACTGTTTAAGGAGTTAGTGGATTACTGCC ATTCACTTCATAATCCAGTAGGATCCAGTGATCCTTACAAGTTAGAAAACATAATCTTCTGCCTTCTCATGATCCAACTAATGCCTTACTCTTCTTGAAATTTTAACCTATGATATTTTC TGTGCCTGAATATTTGTTATGTAGATAACAAGACCTCAGTGCCTTCCTGTTTTTCACATTTTCCTTTTCAAATAGGGTCTAACTCAGCAACTCGCTTTAGGTCAGCAGCCTCCCTGAAGA CCAAAATTAGAATATCCATGACCTAGTTTTCCATGCGTGTTTCTGACTCTGAGCTACAGAGTCTGGTGAAGCTCACTTCTGGGCTTCATCTGGCAACATCTTTATCCGTAGTGGGTATGG TTGACACTAGCCCAATGAAATGAATTAAAGTGGACCAATAGGGCTGAGCTCTCTGTGGGCTGGCAGTCCTGGAAGCCAGCTTTCCCTGCCTCTCATCAACTGAATGAGGTCAGCATGTCT ATTCAGCTTCGTTTATTTTCAAGAATAATCACGCTTTCCTGAATCCAAACTAATCCATCACCGGGGTGGTTTAGTGGCTCAACATTGTGTTCCCATTTCAGCTGATCAGTGGGCCTCCAA GGAGGGGCTGTAAAATGGAGGCCATTGTGTGAGCCTATCAGAGTTGCTGCAAACCTGACCCCTGCTCAGTAAAGCACTTGCAACCGTCTGTTATGCTGTGACACATGGCCCCTCCCCCTG CCAGGAGCTTTGGACCTAATCCAAGCATCCCTTTGCCCAGAAAGAAGATGGGGGAGGAGGCAGTAATAAAAAGATTGAAGTATTTTGCTGGAATAAGTTCAAATTCTTCTGAACTCAAAC TGAGGAATTTCACCTGTAAACCTGAGTCGTACAGAAAGCTGCCTGGTATATCCAAAAGCTTTTTATTCCTCCTGCTCATATTGTGATTCTGCCTTTGGGGACTTTTCTTAAACCTTCAGT TATGATTTTTTTTTCATACACTTATTGGAACTCTGCTTGATTTTTGCCTCTTCCAGTCTTCCTGACACTTTAATTACCAACCTGTTACCTACTTTGACTTTTTGCATTTAAAACAGACAC TGGCATGGATATAGTTTTACTTTTAAACTGTGTACATAACTGAAAATGTGCTATACTGCATACTTTTTAAATGTAAAGATATTTTTATCTTTATATGAAGAAAATCACTTAGGAAATGGC TTTGTGATTCAATCTGTAAACTGTGTATTCCAAGACATGTCTGTTCTACATAGATGCTTAGTCCCTCATGCAAATCAATTACTGGTCCAAAAGATTGCTGAAATTTTATATGCTTACTGA TATATTTTACAATTTTTTATCATGCATGTCCTGTAAAGGTTACAAGCCTGCACAATAAAAATGTTTAACGGTTAAACAGTCAAAAAAAAAAA |
Protein Sequence | >857 : length: 178 MSGGKYVDSEGHLYTVPIREQGNIYKPNNKAMADELSEKQVYDAHTKEIDLVNRDPKHLNDDVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWFYRLLSALFGIPMALIWGIYFA ILSFLHIWAVVPCIKSFLIEIQCISRVYSIYVHTVCDPLFEAVGKIFSNVRINLQKEI |